메뉴 건너뛰기
American Journal of Clinical Pathology
Volumn 127, Issue 1, 2007, Pages 15-19
Recommendations for the reporting of pleural mesothelioma
Author keywords

[No Author keywords available]
Indexed keywords

CLINICAL ASSESSMENT; CLINICAL PRACTICE; HUMAN; MEDICAL DOCUMENTATION; MEDICAL INFORMATION SYSTEM; MEDICAL RECORD; MEDICAL SOCIETY; PATIENT CARE; PLEURA MESOTHELIOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; ARTICLE; MESOTHELIOMA; PATHOLOGY; PLEURA TUMOR; STANDARD;
EID: 34249095485     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/6A30YQHBMTHEJTEM     Document Type: Review
Times cited : (8)
References (10)
  • 1
    • 0028825114 scopus 로고
    • A proposed new international TNM staging system for malignant pleural mesothelioma: From the International Mesothelioma Interest Group
    • Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma: from the International Mesothelioma Interest Group. Chest. 1995;108:1122-1128.
    • (1995) Chest , vol.108 , pp. 1122-1128
    • Rusch, V.W.1
  • 2
    • 0032732861 scopus 로고    scopus 로고
    • Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically
    • Rusch VW, Venkatraman ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg. 1999;68:1799-1804.
    • (1999) Ann Thorac Surg , vol.68 , pp. 1799-1804
    • Rusch, V.W.1    Venkatraman, E.S.2
  • 3
    • 9544247724 scopus 로고    scopus 로고
    • Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: Results in 120 consecutive patients
    • Sugarbaker DJ, Garcia JP, Richards WG, et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 consecutive patients. Ann Surg. 1996;224:288-294.
    • (1996) Ann Surg , vol.224 , pp. 288-294
    • Sugarbaker, D.J.1    Garcia, J.P.2    Richards, W.G.3
  • 4
    • 0032952875 scopus 로고    scopus 로고
    • Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients
    • Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999;117:54-63.
    • (1999) J Thorac Cardiovasc Surg , vol.117 , pp. 54-63
    • Sugarbaker, D.J.1    Flores, R.M.2    Jaklitsch, M.T.3
  • 5
    • 34249051246 scopus 로고    scopus 로고
    • Churg A, Roggli VL, Galateau-Salle F, et al. Mesothelioma. In: Travis WD, Brambilla E, Muller-Hermelink HK, et al, eds. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus, and Heart. Lyon, France: IARC Press; 2004:128-136. World Health Organization Classification of Tumours.
    • Churg A, Roggli VL, Galateau-Salle F, et al. Mesothelioma. In: Travis WD, Brambilla E, Muller-Hermelink HK, et al, eds. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus, and Heart. Lyon, France: IARC Press; 2004:128-136. World Health Organization Classification of Tumours.
  • 6
    • 12344270308 scopus 로고    scopus 로고
    • Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma
    • Chu AY, Litzky LA, Pasha TL, et al. Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol. 2005;18:105-110.
    • (2005) Mod Pathol , vol.18 , pp. 105-110
    • Chu, A.Y.1    Litzky, L.A.2    Pasha, T.L.3
  • 7
    • 0033955741 scopus 로고    scopus 로고
    • Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura
    • Cury PM, Butcher DN, Fisher C, et al. Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Mod Pathol. 2000;13:107-112.
    • (2000) Mod Pathol , vol.13 , pp. 107-112
    • Cury, P.M.1    Butcher, D.N.2    Fisher, C.3
  • 8
    • 0032512614 scopus 로고    scopus 로고
    • TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung
    • Di Loreto C, Puglisi F, Di Lauro V, et al. TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung. Cancer Lett. 1998;124:73-78.
    • (1998) Cancer Lett , vol.124 , pp. 73-78
    • Di Loreto, C.1    Puglisi, F.2    Di Lauro, V.3
  • 9
    • 0345647093 scopus 로고    scopus 로고
    • Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma
    • Ordonez NG. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol. 1998;22:1215-1221.
    • (1998) Am J Surg Pathol , vol.22 , pp. 1215-1221
    • Ordonez, N.G.1
  • 10
    • 0031983428 scopus 로고    scopus 로고
    • Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma: The M.D. Anderson experience and a critical review of the literature
    • Ordonez NG. Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma: the M.D. Anderson experience and a critical review of the literature. Am J Clin Pathol. 1998;109:85-89.
    • (1998) Am J Clin Pathol , vol.109 , pp. 85-89
    • Ordonez, N.G.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.